What is Sente?
Sente specializes in the development and distribution of medical-grade skincare products designed to address a spectrum of dermatological concerns, including discoloration, redness, and hyperpigmentation. Their product portfolio features targeted solutions such as serums, creams, and masks, all formulated with their proprietary HSA repair molecule. The company emphasizes dermatologist-approved formulations and caters to a broad customer base, including individuals with sensitive skin, aiming to enhance the skin's natural immune response and promote healthier, more even-toned complexions.
How much funding has Sente raised?
Sente has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Sente
PPP
Public-Private Partnership
What's next for Sente?
With a substantial enterprise-level funding context, Sente is positioned for significant scaling and market penetration. The recent capital injection will likely be strategically deployed to enhance research and development, expand manufacturing capabilities, and broaden its market reach. Future growth may involve strategic partnerships, further product line diversification, and increased marketing efforts to solidify its position as a leader in the medical-grade skincare sector. The company's focus on patented technology and scientifically backed formulations provides a strong foundation for sustained expansion and innovation.
See full Sente company page
